Last reviewed · How we verify

NCT06788418

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Recruiting now NA Last updated 23 January 2025
What this trial tests

NA trial testing Wavelight Plus Alcon system in Myopia in 1,000 participants. Currently enrolling.

Timeline
20 January 2025
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorBeijing Visionly Plus Eye Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment1,000
Start date20 January 2025
Primary completion31 December 2025
Estimated completion31 December 2025
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Visionly Plus Eye Hospital

Who can join

Adults 18 to 40, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Beijing Visionly Plus Eye Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06788418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing